Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.
Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference1.0%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check39 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check53 days agoChange DetectedNo new additions were noted, but the website has removed a section detailing download options and data fields related to clinical studies.SummaryDifference14%
- Check60 days agoChange DetectedSeveral key government health and information websites have been removed from the monitored list.SummaryDifference0.7%
- Check68 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links to health-related resources and providing enhanced options for downloading study data in various formats.SummaryDifference17%
Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.